Fatal disseminated cytomegalovirus infection associated with infliximab and 6-mercaptopurine therapy in a child with crohn disease

Pediatric Infectious Disease Journal

Volumn 28, Issue 6, 2009, Pages 556-

  Pickering, Olufunke ^a   Weinstein, Toba ^a   Rubin, Lorry G ^a  

^a SCHNEIDER CHILDREN'S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; FOSCARNET; GANCICLOVIR; IMMUNOGLOBULIN; INFLIXIMAB; MERCAPTOPURINE; TIMENTIN; VANCOMYCIN; VIRUS ANTIGEN;

BLOODY DIARRHEA; CASE REPORT; CHILD; CLINICAL FEATURE; COLITIS; COLONOSCOPY; CROHN DISEASE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DISEASE EXACERBATION; FATALITY; FEVER; HUMAN; HUMAN TISSUE; LETTER; MALE; PAIN; PRIORITY JOURNAL; SCHOOL CHILD; SICKLE CELL ANEMIA;

EID: 67649543946     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3181a39571     Document Type: Letter

References (3)

1. Papadakis KA, Tung JK, Binder SW, et al. Outcome of cytomegalovirus infection in patients with inflammatory bowel disease. Am J Gastroenterol. 2000;96:2137-2142.
2. Ghidini B, Belaiche M, Berrebi D, et al. Cytomegalovirus colitis in children with inflammatory bowel disease. Gut. 2006;55:582-583.
3. Helbling D, Breitbach TH, Krause M. Disseminated cytomegalovirus infection in Crohns disease following anti-tumour necrosis factor therapy. Eur J Gastroenterol Hepatol. 2002;14:1393-1395.